ALBERATI, DANIELA,MOREAU, JEAN-LUC,WETTSTEIN, JOSEPH G.
申请号：
DK11739097
公开号：
DK2603219T3
申请日:
2011.08.05
申请国别(地区):
DK
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical combination of a glycine transporter inhibitor (GlyT1) and an atypical antipsychotic drug which may be used for the treatment of positive and negative symptoms of schizophrenia.
